Mrs. Kei Worry, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 213 Quarry Rd, Palo Alto, CA 94304 Phone: 650-725-5106 Fax: 650-725-5433 |
Silvano Ezequiel Perez Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |
Miss Marlene Ann Specht, MASTER'S DEGREE Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 |
Nicole Wdowiak Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 650 Clark Way, Palo Alto, CA 94304 Phone: 650-326-5330 |
News Archive
Kaiser Health News provides a fresh take on health policy developments with "Exercise Guidelines?" by Chris Wildt.
IRIN examines the efforts of the Geneva-based Foundation for Innovative New Diagnostics (FIND) to develop less costly surveillance equipment to improve the ability to detect the parasitic disease trypanosomiasis (sleeping sickness) in endemic countries.
People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.
Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.
› Verified 2 days ago